EUVIMEDEUVIMED entdecken
Systematische Übersicht

Total Knee Arthroplasty versus Mesenchymal Stem Cell Therapy for Moderate Knee Osteoarthritis: An Umbrella Analysis of Clinical Outcomes, Quality of Life, and Safety

Chayanin Angthong, Tyler Vichayabhai, Phurin Tatiya-Apitham, Wirana Angthong

Ortopedia Traumatologia Rehabilitacja · 31.03.2026 · 28 (1) · 15-22

DOI: 10.5604/01.3001.0055.7770 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Ortopedia Traumatologia Rehabilitacja, erschienen am 31.03.2026. Verfasst von Chayanin Angthong und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Biomedical Engineering, Rangsit University, Pathum Thani, Thailand. Hauptthemen laut MEDLINE: Osteoarthritis, Knee, Mesenchymal Stem Cell Transplantation, Arthroplasty, Replacement, Knee, Quality of Life.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Moderate knee osteoarthritis (Kellgren-Lawrence [KL] Grade 2–3) represents a critical therapeutic crossroads where patients must choose between regenerative strategies and surgical replacement. This umbrella analysis synthesizes current evidence regarding the clinical efficacy, quality of life, and safety profiles of mesenchymal stem cell (MSC) therapy relative to total knee arthroplasty (TKA).

Material and methods. Following PRISMA 2020 guidelines, we systematically searched seven databases (2016–2026). Screening of 1,211 records identified 242 unique papers for full-text assessment. Eligible studies included systematic reviews, meta-analyses, and large prospective cohorts (>50 participants) evaluating intra-articular MSCs or TKA in KL Grade 2–3 populations with ≥12-month follow-up.

Results

Our analysis reveals a profound evidence gap: zero studies directly compared MSC therapy to TKA in this population. Data from 30 high-quality studies demonstrate that MSC therapy significantly outperforms placebo and conservative management, yielding VAS pain reductions of 20–40 points and WOMAC functional improvements of 15–35 points at 12–24 months. Adipose-derived MSCs showed superior analgesia, while umbilical cord-derived MSCs optimized functional recovery. MSC therapy significantly reduced the hazard of TKA conversion (HR 0.52, p<0.001). At 36–60 months, conversion rates were 12.4% for MSCs versus 22.7% for control groups. Safety profiles remained favorable with serious adverse event rates <5%.

Conclusions

1. While MSC therapy is a demonstrably effective bridge for delaying TKA in selected KL Grade 2–3 patients, its comparative effectiveness and long-term durability relative to arthroplasty remain uncharacterized. 2. High-quality randomized controlled trials directly benchmarking MSCs against TKA are urgently required to resolve this clinical impasse and inform treatment algorithms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Osteoarthritis, KneeMesenchymal Stem Cell TransplantationArthroplasty, Replacement, KneeQuality of LifeHumansFemaleTreatment OutcomeMaleMiddle AgedAged

Stichwörter der Autor:innen

Kellgren-Lawrence gradeKey words: knee osteoarthritisPRISMA 2020mesenchymal stem cellsquality of liferegenerative medicinetotal knee arthroplasty

Autor:innen und Institutionen

  • College of Biomedical Engineering, Rangsit University, Pathum Thani, Thailand.
  • Faculty of Medicine, King Mongkut's Institute of Technology Ladkrabang, Bangkok, Thailand.
  • Department of Radiology, Faculty of Medicine, Thammasat University, Pathum Thani, Thailand.

Zitieren

APA

Angthong, C., Vichayabhai, T., Tatiya-Apitham, P., & Angthong, W. (2026). Total Knee Arthroplasty versus Mesenchymal Stem Cell Therapy for Moderate Knee Osteoarthritis: An Umbrella Analysis of Clinical Outcomes, Quality of Life, and Safety. Ortopedia Traumatologia Rehabilitacja, 28(1), 15-22. https://doi.org/10.5604/01.3001.0055.7770

Vancouver

Angthong C, Vichayabhai T, Tatiya-Apitham P, Angthong W. Total Knee Arthroplasty versus Mesenchymal Stem Cell Therapy for Moderate Knee Osteoarthritis: An Umbrella Analysis of Clinical Outcomes, Quality of Life, and Safety. Ortopedia Traumatologia Rehabilitacja. 2026;28(1):15-22. doi:10.5604/01.3001.0055.7770

BibTeX
@article{Angthong2026,
  author = {Angthong, Chayanin and Vichayabhai, Tyler and Tatiya-Apitham, Phurin and Angthong, Wirana},
  title = {Total Knee Arthroplasty versus Mesenchymal Stem Cell Therapy for Moderate Knee Osteoarthritis: An Umbrella Analysis of Clinical Outcomes, Quality of Life, and Safety},
  journal = {Ortopedia Traumatologia Rehabilitacja},
  year = {2026},
  volume = {28},
  number = {1},
  pages = {15--22},
  doi = {10.5604/01.3001.0055.7770}
}
Kostenlos starten →